Premium
A Comparison of the Long‐Term Outcome and Effects of Surgery or Continuous Positive Airway Pressure on Patients with Obstructive Sleep Apnea Syndrome
Author(s) -
Lin ShihWei,
Chen NingHung,
Li HsuehYu,
Fang TuanJen,
Huang ChongChi,
Tsai YiangHuang,
Lee ChengHuei
Publication year - 2006
Publication title -
the laryngoscope
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.181
H-Index - 148
eISSN - 1531-4995
pISSN - 0023-852X
DOI - 10.1097/01.mlg.0000217242.16814.da
Subject(s) - medicine , continuous positive airway pressure , obstructive sleep apnea , polysomnography , respiratory disturbance index , epworth sleepiness scale , body mass index , anesthesia , sleep apnea , positive airway pressure , apnea , surgery
Objectives: To compare the long‐term (3‐year) outcome and effects of continuous positive airway pressure (CPAP) and extended uvulopalatoplasty (EUPF) treatment on patients with obstructive sleep apnea syndrome. Methods: Eighty‐four patients who received CPAP titration and bought a CPAP machine to use from March 2000 to October 2001 were included as the CPAP group. Another 55 patients who underwent EUPF surgery were included as the EUPF group. Overnight polysomnography was performed 6 months and 3 years after CPAP titration or EUPF. The disease‐specific questionnaire‐Snore Outcome Survey (SOS), Epworth Sleepiness Scale (ESS), and the generic health questionnaire‐MOSF‐36 were administered at the 6‐month and 3‐year follow‐up examinations. Results: The age, body mass index, respiratory disturbance index, and ESS before treatment were higher in the CPAP group. The snore index was higher in the surgery group. Fifty‐four patients (64.3%) in CPAP group continued treatment for 6 months; the success rate for EUPF at 6 months was 82%. The polysomnographic variables improved significantly in both groups. Improvements in the SOS and ESS scores were better in surgery group than the CPAP group. The subscales of SF‐36 in surgery group were more than those in CPAP group. Conclusions: EUPF had a better effect on snoring than CPAP 6 months after treatment in patients with obstructive sleep apnea syndrome (OSAS). This effect had gradually declined at the 3‐year follow‐up examination. Improvement in the quality of life of OSAS patients receiving EUPF is equal to those receiving CPAP treatment.